Featured
Development phase
Articles
-
25 February 2026
Mastering regulatory complexity: A Guide to derisking drug development in the US and Europe
News & Updates
Videos
-
20 January 2026
Cell and Gene Therapy Answers: What Sets Regenerative Cell Therapy Apart?
Articles
-
16 December 2025
Accelerating complex drug metabolism testing with remarkable speed
Articles
-
28 March 2025
Rapid and robust preclinical development of CAR T-cell therapies
Articles
-
8 November 2024
Cell and Gene Therapy Answers: Top considerations for ocular cell and gene therapies
Discovery
Articles
—
18 February Feb 2025
Articles
—
1 May May 2024
Articles
—
4 January Jan 2024
Nonclinical/preclinical
Articles
—
25 February Feb 2026
Videos
—
20 January Jan 2026
Trial design & strategy
Market access strategy
Articles
-
2 June 2022
Case Study - Data Extraction Presentation
Articles
-
11 May 2022
Cardiovascular Outcome Trials: Strategic Insights for Country and Site Distribution
Articles
-
10 December 2021
Policy and Reimbursement Considerations in Early Clinical Development
Patient recruitment
Articles
—
2 December Dec 2022
Articles
—
19 November Nov 2021
Patient support & hub
Articles
—
12 July Jul 2022
Articles
—
13 December Dec 2021
Patient safety & PV
Articles
—
20 July Jul 2021
Articles
—
12 February Feb 2020
Regulatory & strategy
Articles
-
25 February 2026
Mastering regulatory complexity: A Guide to derisking drug development in the US and Europe
Articles
-
15 August 2023
Lessons learned from missing the mark with FDA hot buttons
Articles
-
25 May 2022
Providing Regulatory Support in China for a New Compound
Program Management
Articles
-
17 June 2021
Phase I Hybrid Trials - A guide to successful planning and execution
Articles
-
16 September 2019
Preserving Lifecyles: Renewing Existing Plant Protection Active Substances
Regulatory
Articles
—
25 February Feb 2026
Articles
—
7 October Oct 2025
Articles
—
7 October Oct 2025
Manufacturing
Articles
—
17 June Jun 2021